Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats (Q28572510)

2

1 reference

31 January 2017

Therese Hultstrand

3

1 reference

31 January 2017

Severina Jacinto

4

1 reference

31 January 2017

Germán Camejo

5

1 reference

31 January 2017

Boel Wallin

6

1 reference

31 January 2017

Bengt Ljung

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

7

1 reference

31 January 2017

1 October 2005

1 reference

31 January 2017

1 reference

31 January 2017

289

1 reference

31 January 2017

4

1 reference

31 January 2017

R938–946

1 reference

31 January 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Transport and storage of vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Effect of breakfast fat content on glucose tolerance and risk factors of atherosclerosis and thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Abnormal oral glucose tolerance in genetically obese (fa/fa) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Postprandial lipoprotein metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Recent findings in the study of postprandial lipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Pathogenesis of dyslipidemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00252.2005